Home » Topics » BioWorld Science

BioWorld Science
RSS

Esteve patents dual CACNA2D1/SIGMAR1 ligands

Dec. 22, 2021

Histone-lysine N-methyltransferase 2A inhibitors discovered at Novartis

Dec. 22, 2021

Chiesi identifies new discoidin domain-containing receptor inhibitors

Dec. 22, 2021

RET inhibitor SYHA-1815 induces G1 cell cycle arrest through c-MYC downregulation

Dec. 22, 2021

Extension of Series A financing at Ambys supports progression of AMI-918 for liver disease

Dec. 21, 2021

Choline transporter in fruit fly brain tunes out unnecessary information

Dec. 21, 2021

RaQualia and Hisamitsu to enter license agreement for sodium channel blocker

Dec. 21, 2021

Aridis' AR-701 is broadly reactive against Omicron and other SARS-CoV-2 variants

Dec. 21, 2021

IFI27 as a potential new gene biomarker for severe COVID-19

Dec. 21, 2021

FibroGen exercises license option for HiFiBiO's anti-CCR8 monoclonal antibody program

Dec. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026